Searchable abstracts of presentations at key conferences in endocrinology

ea0063p807 | Thyroid 2 | ECE2019

Breast cancer mimicking metastasis on iodine-131 imaging in thyroid carcinoma

Iyidir Ozlem Turhan , Bozkus Yusuf , Aktas Ayse , Tutuncu Neslihan Bascil

Introduction: Radioiodine ablation with a whole-body scan is a well known therapeutic regimen for differentiated thyroid cancer. I-131 uptake in the breast has been described with a variety of normal and pathologic conditions such as gynecomastia, supernumerary breasts, fibroadenoma and lactational duct cyst or galactocele. Here we report a case with an incidental radioiodine uptake in breast who turned out to be breast cancer.Case report: A 70 years old...

ea0037ep327 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Prevalence of orthorexia in diabetic patients

Anil Cuneyd , Aritici Gozde , Ari Hacer , Tutuncu Neslihan Bascil

Introduction: Orthorexia (nervosa) is an eating disorder, characterised by an obsession with avoiding foods perceived to be unhealthy. Though it has not been recognised as a pathological entity in Diagnostic and Statistical Manual of Mental Disorders – IV yet, interest in the condition has increased recently. This study aimed to determine the prevalence and risk factors of orthorexia in a group of diabetic patients.Methods and design: 134 (63 female...

ea0035p403 | Diabetes complications | ECE2014

Does proton pump inhibitor use decrease microvascular complicaton rate in type 2 diabetic patients? A retrospective analysis

Kut Altug , Bozkus Yusuf , Anil Cuneyd , Tutuncu Neslihan Bascil

Proton pump inhibitor (PPI) drugs which are used safely to treat peptic ulcus disease since 2 decades, moderately increases gastrin hormone by decreasing gastric acid secretion. Preclinical studies show that gastrin itself, or drugs that increase gastrin levels such as PPIs, increase islet cell mass and improve glycaemic control. To the best of our knowledge one prospective and some retrospective studies claim that PPI medication in diabetic patients leads to an average decrea...

ea0035p469 | Diabetes therapy | ECE2014

Effect of angiotensin receptor blockers on glycaemic control in type 2 diabetic patients? A retrospective analysis

Bozkus Yusuf , Kut Altug , Kirnap Nazli , Tutuncu Neslihan Bascil

Experimental and clinical studies suggest that blocking the effects of angiotensin II increases insulin sensitivity, skeletal muscle glucose transport, and pancreatic blood flow which may contribute to the prevention of diabetes mellitus. Although large scale studies and meta-analysis reveal that the new onset of diabetes could be significantly decreased by ARBs in both hypertensive and normotensive patients, their effect on glucose regulation in patients already diagnosed wit...

ea0035p470 | Diabetes therapy | ECE2014

Comparison of angiotensin receptor blockers and angiotensin converting enzyme inhibitors for glycaemic regulation

Kut Altug , Bozkus Yusuf , Firat Sevde Nur , Tutuncu Neslihan Bascil

Large scale clinical studies and meta-analysis suggest that treatment with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) could have protective effect against diabetes development. While diuretics and β-blockers have some well known adverse effect on glycaemic regulation, ARBs/ACEIs’ effect on glucose regulation in patients already diagnosed with diabetes has not been investigated well enough. Also to the best of our knowled...

ea0026p241 | Pituitary | ECE2011

Periodontal disease ferquency in acromegalic patients

Bascil Sibel , Serinsoz Hulya , Ertorer Eda , Tutuncu Neslihan B

Periodontal disease frequency was screened and compared in 15 acromegalic patients with age and sex matched 50 healthy subjects. Periodontal evaluation included panographic radiography, plaque and gingival index and depth determination and clinical parameters. Estimated disease duration was 2–10 years in acromegalic patients (8 female, 7 male patients, 52±13 years). Five patients on somatostain analog therapy had inactive disease for at least 2 years and 10 patients ...

ea0063p769 | Thyroid 2 | ECE2019

The evaluation of peripheral vestibular system in Hashimoto’s thyroiditis

Musayeva Nurcahan , Beyazpinar Gulfem , Iyidir Ozlem Turhan , Oz İsilay , Ozluoglu Levent , Tutuncu Neslihan Bascil

Introduction: The aim of this study is to investigate association between Hashimoto’s thyroiditis (HT) and vestibular function and the possible effect of levothyroxine (LT4) treatment on vestibular functionPatients and methods: We recruited 61 patients with HT and 30 age and gender matched healthy individuals for the study. Of 30 patients with HT were on LT4 treatment (group I) and 31 patients were treatment naive (group II). None of the patients ha...

ea0049ep39 | Adrenal cortex (to include Cushing's) | ECE2017

The clinical course of patients with adrenal incidentaloma: Başkent University experience

Kirnap Nazli Gulsoy , Iyidir Ozlem Turhan , Bozkus Yusuf , Ramazanova Lala , Nar Asli , Kut Altug , Tutuncu Neslihan

The prevalance of incidentally discovered adrenal masses increased in last three decades. The major clinical concern is the risk of malignancy and hormone overproduction but most of them are non-fonctional and benign. Current practices in the management of adrenal incidentalomas reevaluated the follow-up suggestions considering low probability of the transformation of a benign and non-functional adrenal mass to a malignant or functional one. Therefore, in the present study we ...

ea0049ep1431 | Thyroid (non-cancer) | ECE2017

GA/GG Heterozygosity of ARG280HIS polymorphism in XRCC1 GENE: Genetic susceptibility genotype in differentiated thyroid cancer?

Kirnap Nazli Gulsoy , Tutuncu Neslihan Bascil , Yalcin Yaprak , Verdi Hasibe , Nar Asli , Atac Belgin

Background: Thyroid carcinomas are the most frequent endocrine malignancies of which more than nighty percent are differentiated thyroid carcinomas (DTC). It’s known that genetic variation plays 75% role in the development of papillary thyroid carcinoma (PTC).Material and methods: In a case control setting subjects between January 2005 and December 2015 were evaluated for inclusion in the study. We aimed to compare the genotype frequency distributio...

ea0041ep912 | Pituitary - Clinical | ECE2016

A neurosarcoidosis case with pituitary stalk involvement manifesting as hypogonadism and hyperprolactinemia

Nar Asli , Iyidir Ozlem Turhan , Firat Sevde Nur , Tutuncu Neslihan Bascil

Sarcoidosis is a multisystem granulomatous disease of unknown cause. The prevalence of neurosarcoidosis is about 5–15%. Hypothalamo-pituitary sarcoidosis is even rarer (<1% of cases evaluated for sellar and stalk lesions).Case Report: A 33-year-old man presented to urology department with erectile dysfunction which started six months ago. Hormonal evaluation revealed gonadotropin deficiency and hyperprolactinemia (Total testosterone: 30.5 ng/dl,...